DW34 is an orally active pan-BRD4-D1 biased inhibitor with additional BRD4-D2 inhibitive activity. DW34 displays comparable inhibitive efficacy to I-BET151 ( HY-13235 ) ( EC 50 = 0.16 μM) with low nanomolar EC 50 values of 0.14 μM. DW34 significantly reduces liver inflammation induced by LPS ( HY-D1056 ) and APAP ( HY-66005 ) via reducing chemokine expression and cellular necrosis.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Epigenetic Reader Domain | Products > Signaling Pathways > Necroptosis
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.